Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Polsky

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Melanoma Research|April 27, 2019
Impact of initial stage on metastatic melanoma survivalMelissa A Wilson, Judy Zhong, Brooke E Rosenbaum, et al.
Oncology|September 7, 2013
Impact of age on the management of primary melanoma patientsNathaniel H Fleming, Jiaying Tian, Eleazar Vega-Saenz de Miera, et al.
Cancer|April 8, 2011
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survivalJan Zakrzewski, Laurel N Geraghty, Amy E Rose, et al.
The American Journal of Surgical Pathology|May 1, 2013
Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysisChristopher S Hale, Meng Qian, Michelle W Ma, et al.
Plos One|January 12, 2012
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanomaMolly Yancovitz, Adam Litterman, Joanne Yoon, et al.
Journal of the National Cancer Institute|December 5, 2002
HDM2 protein overexpression and prognosis in primary malignant melanomaDavid Polsky, Kate Melzer, Carole Hazan, et al.
Scientific Reports|July 17, 2019
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)Robert Ferguson, Alexi Archambault, Danny Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2009
Phosphorylated 4E-BP1 is associated with poor survival in melanomaKathryn E O'Reilly, Melanie Warycha, Michael A Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patientsMarija Drobnjak, Jonathan Melamed, Samir Taneja, et al.
International Journal of Cancer|August 10, 2004
Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patientsIman Osman, Melissa Kang, Andy Lee, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Melanoma Research|April 27, 2019
Impact of initial stage on metastatic melanoma survivalMelissa A Wilson, Judy Zhong, Brooke E Rosenbaum, et al.
Oncology|September 7, 2013
Impact of age on the management of primary melanoma patientsNathaniel H Fleming, Jiaying Tian, Eleazar Vega-Saenz de Miera, et al.
Cancer|April 8, 2011
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survivalJan Zakrzewski, Laurel N Geraghty, Amy E Rose, et al.
The American Journal of Surgical Pathology|May 1, 2013
Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysisChristopher S Hale, Meng Qian, Michelle W Ma, et al.
Plos One|January 12, 2012
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanomaMolly Yancovitz, Adam Litterman, Joanne Yoon, et al.
Journal of the National Cancer Institute|December 5, 2002
HDM2 protein overexpression and prognosis in primary malignant melanomaDavid Polsky, Kate Melzer, Carole Hazan, et al.
Scientific Reports|July 17, 2019
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)Robert Ferguson, Alexi Archambault, Danny Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2009
Phosphorylated 4E-BP1 is associated with poor survival in melanomaKathryn E O'Reilly, Melanie Warycha, Michael A Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patientsMarija Drobnjak, Jonathan Melamed, Samir Taneja, et al.
International Journal of Cancer|August 10, 2004
Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patientsIman Osman, Melissa Kang, Andy Lee, et al.
Pageof 12